Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04350710
Other study ID # 2030/31
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 18, 2020
Est. completion date December 31, 2020

Study information

Verified date April 2020
Source University Hospital, Angers
Contact François BELONCLE, MCU PH
Phone 0241345866
Email Francois.Beloncle@chu-angers.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this observationnal study is to describe respiratory mechanics and lung recruitement in patients with SARS-CoV-2 Associated Acute Respiratory Distress Syndrome who underwent invasive ventilation on endotracheal tube, admitted to the medical ICU of Angers university hospital . Statics measurements of respiratory system compliance were performed at 2 differents levels of PEEP (15 cmH2O and 5 cmH2O). The recruited volume is computed as the difference between the volume expired from PEEP 15 to 5 cmH2O and the volume predicted by compliance at PEEP 5 cmH2O . The recruitment-to-Inflation (R/I) ratio (i.e. the ratio between the recruited lung compliance and CRS at PEEP 5 cmH2O) is used to assess lung recruitability. A R/I ratio value higher than or equal to 0.5 was used to define highly recruiter patients.


Description:

The investigators perform an observational prospective study in patients admitted to medical ICU in Angers University hospital with a confirmed COVID 19 pneumonia and who require invasive ventilation on endotracheal tube. Participants receive initially deep sedation and neuromuscular blockers for 24 hours and are ventilated in volume-controlled mode with a tidal volume of 6 mL/kg of predicted body weight, a constant inspiratory flow of 60 L/minute and a respiratory rate adjusted to maintain pH above 7.35 when possible. A PEEP decremental trial from 15 to 5 cmH2O was performed (15 minutes by step).

Esophageal pressure monitoring and electrical impedance tomography (EIT) are collected if available. Arterial blood gases and respiratory mechanics are measured at the end of each step.

The recruitment-to-Inflation (R/I) ratio (i.e. the ratio between the recruited lung compliance and CRS at PEEP 5 cmH2O) is used to assess lung recruitability. A R/I ratio value higher than or equal to 0.5 is used to define highly recruiter patients.

By the end of the recording time, a low-flow (5 L/min) inflation from PEEP 5 cmH2O (tidal volume = 6ml/kg PBW) is then performed after a prolonged expiration to identify a potential airway closure and the corresponding airway opening pressure (AOP).

Investigators perform these measurements at day 1, day 5 and day 10 from ICU admission if participants still require controlled ventilation.

The investigators also collect clinical data about each participant (past medical history, ICU discharge, hospital discharge, date of death, ventilator acquired pneumonia, thromboembolic event, use of NO, use of ECMO or renal replacement therapy).


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 31, 2020
Est. primary completion date April 20, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- ARDS criteria according to Berlin classification criteria

- Invasive mechanical ventilation on endotracheal tube

- SARS Cov-2 infection

Exclusion Criteria:

- pneumothorax

Study Design


Related Conditions & MeSH terms


Intervention

Other:
PEEP trial
Measurement of Recruitment-to-Inflation Ratio

Locations

Country Name City State
France CHU Angers

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment-to Inflation ratio (R/I ratio) no unit Day 1
Primary Recruitment-to Inflation ratio (R/I ratio) no unit Day 5
Primary Recruitment-to Inflation ratio (R/I ratio) no unit Day 10
Secondary PaO2/FiO2 (mmHg) Arterial blood gases Day 1
Secondary PaO2/FiO2 (mmHg) Arterial blood gases Day 5
Secondary PaO2/FiO2 (mmHg) Arterial blood gases Day 10
Secondary Lung volume recruited (VRec) mL Day 1
Secondary Lung volume recruited (VRec) mL Day 5
Secondary Lung volume recruited (VRec) mL Day 10
Secondary Plateau pressure (cm H2O) Obtained by inspiratory pause of 5 seconds Day 1
Secondary Plateau pressure (cm H2O) Obtained by inspiratory pause of 5 seconds Day 5
Secondary Plateau pressure (cm H2O) Obtained by inspiratory pause of 5 seconds Day 10
Secondary Oesophagal pressure (cm H2O) Day 1
Secondary Oesophagal pressure (cm H2O) Day 5
Secondary Oesophagal pressure (cm H2O) Day 10
Secondary weight (Kg) Day 1
Secondary weight (Kg) Day 5
Secondary weight (Kg) Day 10
Secondary urine output (mL) day 1
Secondary urine output (mL) day 5
Secondary urine output (mL) day 10
Secondary serum creatinine (Umo/L) day 1
Secondary serum creatinine (Umo/L) day 5
Secondary serum creatinine (Umo/L) day 10
Secondary Mean arterial pressure (mmHg) day 1
Secondary Mean arterial pressure (mmHg) day 5
Secondary Mean arterial pressure (mmHg) day 10
Secondary Peak Pressure (cm H2O) Day 1
Secondary Peak Pressure (cm H2O) Day 5
Secondary Peak Pressure (cm H2O) Day 10
Secondary PEEP total (cm H2O) Obtained by expiratory pause of 5 seconds Day 1
Secondary PEEP total (cm H2O) Obtained by expiratory pause of 5 seconds Day 5
Secondary PEEP total (cm H2O) Obtained by expiratory pause of 5 seconds Day 10
Secondary PEP Set (cm H2O) Day 1
Secondary PEP Set (cm H2O) Day 5
Secondary PEP Set (cm H2O) Day 10
Secondary Height (cm) Day 1
Secondary Airway pening pressure (cm H2O) day 1
Secondary Airway pening pressure (cm H2O) day 5
Secondary Airway pening pressure (cm H2O) day 10
Secondary Expired volume in PEEP setted at 15 cmH2O (mL) respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted Day 1
Secondary Expired volume in PEEP setted at 15 cmH2O (mL) respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted Day 5
Secondary Expired volume in PEEP setted at 15 cmH2O (mL) respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted Day 10
Secondary Expired volume in PEEP setted at 5 cmH2O (mL) respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted Day 1
Secondary Expired volume in PEEP setted at 5 cmH2O (mL) respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted Day 5
Secondary Expired volume in PEEP setted at 5 cmH2O (mL) respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted Day 10
See also
  Status Clinical Trial Phase
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Recruiting NCT05535543 - Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
Completed NCT04695392 - Restore Resilience in Critically Ill Children N/A
Terminated NCT04972318 - Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia N/A
Completed NCT04534569 - Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
Completed NCT04078984 - Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
Completed NCT04451291 - Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure N/A
Not yet recruiting NCT06254313 - The Role of Cxcr4Hi neutrOPhils in InflueNza
Not yet recruiting NCT04798716 - The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 Phase 1/Phase 2
Withdrawn NCT04909879 - Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome Phase 2
Not yet recruiting NCT02881385 - Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation N/A
Terminated NCT02867228 - Noninvasive Estimation of Work of Breathing N/A
Completed NCT02545621 - A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
Withdrawn NCT02253667 - Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients N/A
Completed NCT02232841 - Electrical Impedance Imaging of Patients on Mechanical Ventilation N/A
Completed NCT02889770 - Dead Space Monitoring With Volumetric Capnography in ARDS Patients N/A
Completed NCT01504893 - Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia N/A
Withdrawn NCT01927237 - Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide N/A
Completed NCT01680783 - Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure N/A
Completed NCT02814994 - Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients N/A